NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy
Clinical trial NCT04112641 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04112641
- Sponsor
- Donna Hammond, PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2026-06-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.